Benzinga | May 11, 2021 04:22PM EDT

Tarsus Pharmaceuticals Q1 EPS $0.47 Up From $(0.74) YoY, Sales $33.43M

Tarsus Pharmaceuticals (NASDAQ:TARS) reported quarterly earnings of $0.47 per share. This is a 163.51 percent increase over losses of $(0.74) per share from the same period last year. The company reported $33.43 million in sales this quarter.